Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
about
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@en
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@nl
type
label
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@en
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@nl
prefLabel
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@en
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@nl
P2093
P2860
P1476
Risks of CIN 2+, CIN 3+, and C ...... Cervical Screening Guidelines.
@en
P2093
Barbara Fetterman
Brian Befano
Li C Cheung
Maria Demarco
Nancy E Poitras
Philip E Castle
Richard S Guido
Thomas S Lorey
Walter K Kinney
P2860
P304
P356
10.1097/LGT.0000000000000343
P577
2017-10-01T00:00:00Z